Post‐transplant lymphoproliferative disorders (PTLD) are a recognized complication of the
immunosuppression required to prevent allograft rejection, occurring in 1–20% of recipients …

A joint working group established by the Haemato‐oncology subgroup of the British
Committee for Standards in Haematology (BCSH) and the British Transplantation Society …

Posttransplant Lymphoproliferative Disorders in Liver Transp... : Annals of Surgery
Posttransplant Lymphoproliferative Disorders in Liver Transplantation: A 20-Year …

Productive hepatitis C virus (HCV) infection appears to be primarily, and in most patients
almost exclusively, confined to the liver. However, a wide variety of extrahepatic disease …

Over the past 30 years, organ transplantation has been transformed from an interesting
experiment in human immunobiology to the most practical means of rehabilitating patients …

Abstract Key Points 1 Recurrent and de novo malignancies are the second leading causes
of late death in liver transplant recipients, following age‐related cardiovascular …

Posttransplant malignancies have become a serious long‐term complication after liver
transplantation. Our aim was to compare the incidence of posttransplant cancers with …

This article covers lymphoproliferative disorders in patients with primary or acquired
immunodeficiencies. Primary immunodeficiences include Ataxia Telangiectasia and X …

In a prior multiorgan transplant database study, recipient Epstein–Barr virus (EBV)
seronegativity was not associated with increased risk for posttransplant lymphoproliferative …

The aim of this study was to evaluate the association between hepatitis C virus (HCV)
infection and non‐Hodgkin's lymphoma (NHL), multiple myeloma (MM), thyroid cancer (TC) …